Core Insights - Southwest Airlines has launched an in-house vacation package product called Getaways by Southwest, aimed at providing customers with a convenient and flexible vacation booking experience [1][2] Group 1: Product Features - Getaways by Southwest offers bundled vacation packages that include air travel, hotel accommodations, car rentals, and ground transportation to popular destinations such as Las Vegas, Orlando, Hawaii, Cancun, Punta Cana, and Montego Bay [2] - Customers booking through Getaways can check two bags for free and earn five Rapid Rewards points for every dollar spent on bookings [2] - The product allows customers to cancel their packages and receive vacation travel credits valid for 18 months, with the flexibility to make changes without incurring a change fee [2][4] Group 2: Company Overview - Southwest Airlines operates one of the most admired airlines globally, serving 117 airports across 11 countries and carrying more air travelers within the U.S. than any other airline as of Q1 2025 [5][6] - The company has a workforce of over 72,000 employees and served more than 140 million customers in 2024, emphasizing its commitment to customer service and community engagement [5][6]

SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that the advisors of Zarra Wealth Management have joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA) platform. They reported serving approximately $270 million in advisory, brokerage and retirement plan assets* and join LPL from Ameriprise. Based on Long Island, in Westbury, NY, the team consists of Christopher Zarra, CFP®, CHFC®, CFS®, James Kelly CFP®, APMA™ and Michele Welch, CFP®. They bring 48 years of ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

- Conference Call Scheduled for Tuesday, August 26, 2025 at 11:00 am Eastern Time / 4:00 pm UK Time -NEW YORK and LONDON, Aug. 19, 2025 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA) (the "Company") today announced that its second quarter 2025 financial results will be released prior to market open on Tuesday, August 26, 2025. The Company will also host a conference call and webcast at 11:00am Eastern Time / 4:00pm UK time on the same day to discuss its financial results. Investors and ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Petco investors who were adversely affected by alleged securities fraud between January 14, 2021 and June 5, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/petco-lawsuit-su ...

Core Viewpoint - A class action securities lawsuit has been filed against Sarepta Therapeutics, Inc. due to alleged securities fraud affecting investors between June 22, 2023, and June 24, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Sarepta made false statements regarding the safety of its gene therapy, ELEVIDYS, for Duchenne muscular dystrophy, which posed significant risks to patients [2] - It is alleged that the trial protocols for ELEVIDYS failed to identify severe side effects, leading to potential halting of recruitment and dosing, increased regulatory scrutiny, and risks to the therapy's approvals [2] - The defendants are accused of materially misleading investors and lacking a reasonable basis for their positive statements about ELEVIDYS [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4] - The firm has over 70 employees dedicated to serving clients in complex securities litigation [4]

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in KinderCare Learning Companies, Inc. ("KinderCare Learning Companies, Inc." or the "Company") (NYSE: KLC) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KinderCare Learning Companies, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of KinderCare common stock in or traceable to the Company's October 2024 ...

Core Viewpoint - A class action securities lawsuit has been filed against Replimune Group, Inc. due to alleged securities fraud affecting investors between November 22, 2024, and July 21, 2025 [1][2] Group 1: Lawsuit Details - The complaint alleges that defendants made false statements regarding the IGNYTE trial's prospects, which were known to be inadequate and poorly controlled by the FDA [2] - Defendants' statements about Replimune's business and operations were materially false and misleading, lacking a reasonable basis during the relevant time [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 22, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lineage, Inc. ("Lineage, Inc." or the "Company") (NASDAQ: LINE) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lineage, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with the Company's July 26, 2024 initial publi ...